Literature DB >> 11557589

Identification of a region of strong discrimination in the pore of CFTR.

N A McCarty1, Z R Zhang.   

Abstract

The variety of methods used to identify the structural determinants of anion selectivity in the cystic fibrosis transmembrane conductance regulator Cl(-) channel has made it difficult to assemble the data into a coherent framework that describes the three-dimensional structure of the pore. Here, we compare the relative importance of sites previously studied and identify new sites that contribute strongly to anion selectivity. We studied Cl(-) and substitute anions in oocytes expressing wild-type cystic fibrosis transmembrane conductance regulator or 12-pore-domain mutants to determine relative permeability and relative conductance for 9 monovalent anions and 1 divalent anion. The data indicate that the region of strong discrimination resides between T338 and S341 in transmembrane 6, where mutations affected selectivity between Cl(-) and both large and small anions. Mutations further toward the extracellular end of the pore only strongly affected selectivity between Cl(-) and larger anions. Only mutations at S341 affected selectivity between monovalent and divalent anions. The data are consistent with a narrowing of the pore between the extracellular end and a constriction near the middle of the pore.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11557589     DOI: 10.1152/ajplung.2001.281.4.L852

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  36 in total

1.  Differential contribution of TM6 and TM12 to the pore of CFTR identified by three sulfonylurea-based blockers.

Authors:  Guiying Cui; Binlin Song; Hussein W Turki; Nael A McCarty
Journal:  Pflugers Arch       Date:  2011-12-13       Impact factor: 3.657

2.  Alternating access to the transmembrane domain of the ATP-binding cassette protein cystic fibrosis transmembrane conductance regulator (ABCC7).

Authors:  Wuyang Wang; Paul Linsdell
Journal:  J Biol Chem       Date:  2012-02-01       Impact factor: 5.157

3.  Inhibition of ClC-2 chloride channels by a peptide component or components of scorpion venom.

Authors:  C H Thompson; D M Fields; P R Olivetti; M D Fuller; Z R Zhang; J Kubanek; N A McCarty
Journal:  J Membr Biol       Date:  2005-11       Impact factor: 1.843

4.  Molecular determinants and role of an anion binding site in the external mouth of the CFTR chloride channel pore.

Authors:  Xiandi Gong; Paul Linsdell
Journal:  J Physiol       Date:  2003-04-04       Impact factor: 5.182

Review 5.  Architecture and functional properties of the CFTR channel pore.

Authors:  Paul Linsdell
Journal:  Cell Mol Life Sci       Date:  2016-10-03       Impact factor: 9.261

6.  Cystic fibrosis transmembrane conductance regulator: using differential reactivity toward channel-permeant and channel-impermeant thiol-reactive probes to test a molecular model for the pore.

Authors:  Christopher Alexander; Anthony Ivetac; Xuehong Liu; Yohei Norimatsu; Jose R Serrano; Allison Landstrom; Mark Sansom; David C Dawson
Journal:  Biochemistry       Date:  2009-10-27       Impact factor: 3.162

7.  On the mechanism of CFTR inhibition by a thiazolidinone derivative.

Authors:  Zoia Kopeikin; Yoshiro Sohma; Min Li; Tzyh-Chang Hwang
Journal:  J Gen Physiol       Date:  2010-11-15       Impact factor: 4.086

8.  Cysteine scanning of CFTR's first transmembrane segment reveals its plausible roles in gating and permeation.

Authors:  Xiaolong Gao; Yonghong Bai; Tzyh-Chang Hwang
Journal:  Biophys J       Date:  2013-02-19       Impact factor: 4.033

9.  Novel residues lining the CFTR chloride channel pore identified by functional modification of introduced cysteines.

Authors:  Mohammad Fatehi; Paul Linsdell
Journal:  J Membr Biol       Date:  2009-04-19       Impact factor: 1.843

10.  The CFTR ion channel: gating, regulation, and anion permeation.

Authors:  Tzyh-Chang Hwang; Kevin L Kirk
Journal:  Cold Spring Harb Perspect Med       Date:  2013-01-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.